Provided by Tiger Trade Technology Pte. Ltd.

NovoCure

14.87
+0.46003.19%
Volume:1.35M
Turnover:19.98M
Market Cap:1.67B
PE:-9.25
High:14.95
Open:14.27
Low:14.13
Close:14.41
52wk High:28.56
52wk Low:10.70
Shares:111.98M
Float Shares:94.15M
Volume Ratio:0.98
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6074
EPS(LYR):-1.5638
ROE:-50.60%
ROA:-8.30%
PB:4.88
PE(LYR):-9.51

Loading ...

It’s Earnings Warning Season. How to Profit From Others’ Misery

Dow Jones
·
Jan 01

Novocure to Present at J.P. Morgan Healthcare Conference

Reuters
·
Dec 22, 2025

Does NovoCure’s (NVCR) Internal CEO Transition Reinforce or Recast Its Tumor Treating Fields Strategy?

Simply Wall St.
·
Dec 10, 2025

How Investors Are Reacting To NovoCure (NVCR) CEO Transition as Frank Leonard Takes the Helm

Simply Wall St.
·
Dec 02, 2025

BRIEF-Novocure Appoints Company President Frank Leonard As Chief Executive Officer

Reuters
·
Dec 01, 2025

NovoCure Names Frank Leonard as Chief Executive

MT Newswires Live
·
Dec 01, 2025

Novocure Names Frank Leonard as Chief Executive Officer

Reuters
·
Dec 01, 2025

Novocure Ltd - Frank Leonard Succeeds Ashley Cordova as CEO

THOMSON REUTERS
·
Dec 01, 2025

Novocure to Present at Piper Sandler Healthcare Conference

Reuters
·
Nov 26, 2025

Should Rising Losses Despite Higher Sales Require Action From NovoCure (NVCR) Investors?

Simply Wall St.
·
Nov 13, 2025

Novocure to Present at Jefferies Global Healthcare Conference

Reuters
·
Nov 12, 2025

NovoCure (NVCR): Assessing Valuation Following Q3 Sales Growth and Rising Net Losses

Simply Wall St.
·
Nov 11, 2025

NovoCure’s Mixed Q3: Growth Amid Challenges

TIPRANKS
·
Nov 01, 2025

Novocure Ltd. Reports Q3 2025 Financial Results

TIPRANKS
·
Oct 31, 2025

Novocure Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Oct 31, 2025

Novocure price target raised to $42 from $38 at H.C. Wainwright

TIPRANKS
·
Oct 31, 2025

Stock Track | NovoCure Plunges 5.56% Despite Better-Than-Expected Q3 Revenue as Losses Widen

Stock Track
·
Oct 30, 2025

Novocure reports Q3 EPS (33c), consensus (42c)

TIPRANKS
·
Oct 30, 2025

Stock Track | NovoCure Surges 6.16% Pre-Market on Strong Q3 Results and Regulatory Milestones

Stock Track
·
Oct 30, 2025

Novocure Reports Q3 Revenue Up 8% to $167 Million

Reuters
·
Oct 30, 2025